FHA
FATE icon

Flagship Harbor Advisors’s Fate Therapeutics FATE Stock Holding History

Flagship Harbor Advisors’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-857
Closed -$34K – 915
2020
Q3 		$34K Hold
857
– – ﹤0.01% 967
2020
Q2 		$29K Buy
857
+100
+13% +$2.98K ﹤0.01% 1013
2020
Q1 		$17K Hold
757
– – ﹤0.01% 1081
2019
Q4 		$15K Hold
757
– – ﹤0.01% 1194
2019
Q3 		$11K Hold
757
– – ﹤0.01% 1253
2019
Q2 		$15K Hold
757
– – ﹤0.01% 1165
2019
Q1 		$13K Hold
757
– – ﹤0.01% 1208
2018
Q4 		$9K Hold
757
– – ﹤0.01% 1257
2018
Q3 		$12K Hold
757
– – ﹤0.01% 1320
2018
Q2 		$8K Buy
+757
New +$8.34K ﹤0.01% 1462

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return